Robert Chafin Vice President, Industry Research and Engagement Bluegrass Business Media
As the drug prices continue to increase on an annual basis, pharmacists are continually seeking strategies to manage these increased costs. One potential cost mitigation strategy to the usage of biosimilars. In this session, attendees will gain a broad understanding of the biosimilar industry, including its key scientific principles, manufacturing background, and FDA approval process. They will also gain insight on best practices for biosimilars and how biosimilars can help drive value to different stakeholders.
Learning Objectives:
1. Outline biosimilars, their scientific background, and biologic cost trends.
2. Explain the biosimilar manufacturing and approval process as well as barriers to market entry.
3. Evaluate biosimilars’ value proposition in value-based care.